Injectable nanofiber microspheres to rebuild smooth joint cartilage
Regenerating Hyaline Cartilage Using Nanofibrous Hollow Microspheres and Synergizing TGF-β and HIF
Researchers are developing an injectable microsphere treatment that aims to help adults with damaged joint cartilage by activating their own bone marrow cells to grow new cartilage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10990982 on NIH RePORTER |
What this research studies
Researchers will use biodegradable nanofibrous hollow microspheres as an injectable carrier that can deliver biological factors to the joint. The microspheres are designed to release TGF-β and a drug that stabilizes HIF proteins to steer bone marrow stem cells toward making durable hyaline cartilage and to prevent harmful cartilage overgrowth. Laboratory tests will use human and rabbit bone marrow stem cells in cell culture and in a subcutaneous implantation model, followed by testing the injectable approach in a rabbit joint repair model. The goal is a minimally invasive treatment that regenerates and maintains high-quality cartilage instead of scar-like tissue.
Who could benefit from this research
Good fit: Adults with focal or traumatic cartilage defects or early joint cartilage degeneration who are interested in regenerative repair approaches would be the most relevant candidates for this line of work.
Not a fit: People with advanced, widespread osteoarthritis, major bone loss, active inflammatory joint diseases, or those unable or unwilling to travel for experimental procedures are unlikely to benefit from this preclinical project.
Why it matters
Potential benefit: If successful, this could lead to an injectable treatment that helps rebuild durable joint cartilage, reduce pain, and delay or avoid joint replacement.
How similar studies have performed: Previous lab and animal work has shown promise for injectable carriers and growth factors in improving cartilage repair, but durable regeneration of true hyaline cartilage in humans remains largely unproven.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Ma, Peter X — University of Michigan at Ann Arbor
- Study coordinator: Ma, Peter X
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.